Skip to Main Content

Paper Details

The Clinical Implications of Reversions in Patients with Advanced Pancreatic Cancer and Pathogenic Variants in BRCA1, BRCA2, or PALB2 after Progression on Rucaparib.
Clin Cancer Res
0
2023
Advanced Pancreatic Cancer, BRCA, BRCA or PALB2 related, BRCA or PALB2 reversion variants, BRCA- or PALB2-mutated pancreatic cancer, BRCA1, BRCA2, PALB2, PALB2 reversion variants, PARPi, PDAC, Patients, Poly-(ADP-ribose), Poly-(ADP-ribose) polymerase, Rucaparib, advanced, platinum-sensitive pancreatic cancer, cfDNA, cfDNA samples, patients, platinum, rucaparib, tumor
Author NameAffiliation
Katherine L NathansonPerelman School of Medicine, University of Pennsylvania
Susan M DomchekUniversity of Pennsylvania
  • 1 - 2

Datasets

Release 1.2